South Asia Meeting HPV Prevention and Control Landscape and the way forward

Day 1 | Day 2 | Day 3

DAY 1: Tuesday, 13 December 2022

Inauguration & Welcome Note

  • Minister of Health or Health Secretary

SESSION 1: INAUGURAL SESSION

  • Welcome
    Prof Narendra Kumar Arora, INCLEN, Delhi
  • SPC CHIC and HPV Prevention and Control Board
    Prof. Alex Vorsters (University of Antwerp)
  • Opening remarks
    Prof. Neerja Bhatla , AIIMS, New Delhi
    Dr Prashant Mathur, NCDIR-ICMR, Bengaluru
  • SPC Co-chairs: Prof. Margaret Stanley (University of Cambridge, UK) and Dr. Nelly Mugo (Kenya Medical Research Institute, Kenya) 

SESSION 2: HPV RELATED CANCER BURDEN IN THE REGION

Chairs: Dr. Prabhdeep Kaur (India), Dr. Dilip Das (India) & Dr. Kim Mulholland (Australia)

  • Cervical cancer prevention and control; global overview on disease burden, WHO elimination goals and tools to achieve these goals
    Dr. Cherian Varghese (SEARO WHO)
  • Overview of HPV related disease burden, mortality, social and economic impact
    Country Presentations:
    Bangladesh – Dr. Ferdousi Begum, GoB
    India – Mr. Vishal Chauhan, MoHFW, GoI
    Nepal – Dr. Murari Man Shrestha, GoN
    Sri Lanka – Dr. Suraj Perera
    Maldives – Dr. Aminath Nusra, GoMal
    Pakistan – Dr. Fauzia Assad (Jhpiego, Pakistan)
  • Q&A

SESSION 3: CANCER REGISTRIES; GAPS AND THE WAYS TO IMPROVE CERVICAL CANCER DATA COLLECTION

Chairs: Dr Eric Zomawia (MD-Mizoram, India), Dr Ravi Kannan (India) & Ramesh K. Adhikari (Nepal)

  • Cancer registries – data collection, challenges and steps to strengthen registries and improve cervical cancer data collection
    Country presentations:

    India – Dr. Prashant Mathur, ICMR-NCDIR, GoI
    Nepal – Dr. Pradip Gyanwali, GoN
    Bangladesh – Dr. Rifat Ara, NICRH, GoB
    Sri Lanka – Dr Suraj Perera, GoSL
    Pakistan – Prof. Dr. Sarbuland Khan ICCBS University of Karachi, Pakistan (Online)
  • Q&A

SESSION 4: HEALTH SYSTEMS INFORMATION: PEER EXCHANGE ON DATA REPORTING AND COLLECTION MECHANISMS FOR HPV VACCINATION PROGRAMS 

Chairs: Dr Raj Prabha Moktan (MD-Sikkim India), Dr. Joseph Biey (WHO) & Dr. Suzanne Garland (University of Melbourne, Australia)

  • Health information system: overview and challenges
    Data reporting and collection mechanism for HPV vaccination program and the research gaps to improve health information system
    Country presentations- Examples/Experiences

    Maldives – Dr. Jumailath Beygum, GoM
    Sri Lanka – Dr. Samitha Ginige, GoSL
    India (Sikkim state)– Dr. Tsering Doma, GoSikkim, India
  • Q&A

SESSION 4A (PANEL DISCUSSION): PEER EXCHANGE LEARNING ON IMPLEMENTATION AND RESEARCH GAPS IN STRENGTHENING HEALTH INFORMATION SYSTEMS

Chairs: Shri AbhinavTrikha (MD-Punjab, India), Dr. Jyoti Logani (India) & Dr. Cherian Varghese (SEARO WHO)

  • What are the implementation and research gaps in strengthening health information systems in South Asia?
    Panelists
    Bangladesh – Dr Choudhury Ali Kawsar, GoB
    India – Dr Nivedita Gupta
    Maldives – Dr Mariyam Jenyfa
    Sri Lanka – Dr Samitha P. Ginige, GoSL
    Myanmar – Dr Soe Lwin Nyein, GoMN
    Pakistan – Prof. Dr. Shahzad Ali Khan (Health Services Academy, Pakistan)

SESSION 5: PEER EXCHANGE LEARNING AND LEVERAGING OPPORTUNITIES FROM OTHER VACCINATION PROGRAMS

Chairs: Shri Sudhir Kumar Sharma (MD-Rajasthan), Dr F.U. Ahmed (NITAG- India) & Dr Padmaka de Silva (Sri Lanka)

  • Lessons learned on vaccination data collection and reporting mechanism from other vaccination programs in the region
    Country experiences:
  • Intensified Mission Indradhanush/ Measles Rubella Vaccine campaign in India
    Dr. Veena Dhawan, GoI
  • Measles Rubella vaccination experience in Bangladesh
    Dr. Rajib Sarkar
  • Village Full Immunization Certification program in Nepal
    Mr. Sagar Dahal (Department of Health Services, GoN)
  • Ministry of Education involvement in MR vaccination program
    Dr. E. Naveen Nicolas
  • Q&A

DAY 2: INTRODUCTION

Welcome Note for Day 2

  • Dr. Manoja Kumar Das (India)

SESSION 6: HPV VACCINATION PROGRAMS: PEER EXCHANGE ON LESSONS LEARNED FROM PLANNING AND  INTRODUCTION

Chairs: Shri Subashis Das (MD-Tripura, India), Paul Bloem (WHO) & Sunil Bahl (SEARO, WHO)

  • HPV Vaccination Introduction – Global Overview on HPV vaccination introduction status
    Dr Emmanuel Njambe, WHO SEARO
  • HPV vaccine roll-out in Sri Lanka; lessons learned from planning process
    Dr. Samitha Ginige, GoSL
  • HPV Vaccine roll-out experience in Sikkim: lessons learned for sustainable coverage
    Dr. Tsering Doma, GoSikkim, India
  • Planning Roadmap towards HPV Vaccination Introduction
    Dr. Fauzia Assad & Dr. Arshad Chandio (Jhpiego, Pakistan)
  • Q&A

SESSION 6A:  PEER EXCHANGE ON STAKEHOLDER ENGAGEMENT AND SUSTAINABLE DELIVERY PLATFORMS FOR HPV VACCINATION PROGRAMS

Chairs: Shri Rajesh Bhushan (Secretary, MoHFW-India), Dr Mohammad Tofazzal Hossain (DGHS, MoH-Bangladesh) & Anita Karwal (Fmr. Secretary Education, GOI)

  • Adolescent health integration with HPV vaccination program
    Experience from Tanzania
    Pricillah Kinyunyi, MOH Tanzania
  • Adolescent health integration: leveraging opportunities
    Example from Tamil Nadu State, India

    Dr. Vinay, Go Tamil Nadu, India
  • Overview on HPV vaccination delivery approaches and platforms
    Ms. Sarah Wanyoike (Jhpiego, USA) & Dr. Prem Singh (Jhpiego, India)
  • Lessons learned on delivery approaches from CHIC Africa symposium
    Prof. Dr. Alex Vorsters, Mrs. Dur-e-Nayab Waheed
  • Country experience from Maldives on delivery approaches
    Dr. Jumailath Beygum, GoM
  • Q&A

SESSION 7: HPV VACCINATION PROGRAMS: OVERVIEW OF GAVI’S SUPPORT FOR HPV VACCINATION PROGRAMS IN LOW AND MIDDLE INCOME COUNTRIES (LMICS)

Chairs: Dr. Mathuram Santosham (JHU, USA), Dr. Anissa Sidibe (Gavi) & Dr. Myo Myo Mon (MoH-Myanmar)

  • Overview of Gavi’s support for HPV vaccination programs in low and middle income countries (LMICs)
    Mr. Homero Hernandez, Gavi
  • Q&A

SESSION 8: HPV VACCINATION PROGRAMS: WHO POSITION PAPER ON NEW RECOMMENDATION AND GLOBAL OVERVIEW ON HPV VACCINE EFFICACY AND SAFETY

Chairs: Smt. Aparna U (MD, UP) & Dr. Asela Gunawardena (DGHS,GO Sri Lanka)

  • WHO position paper on new recommendation and Global overview on HPV vaccine efficacy and safety
    Mr. Paul Bloem (WHO)
  • Q&A

SESSION 9: ONE DOSE; THE CURRENT SCENARIO AND THE WAY FORWARD

Chairs: Ms. Ayushi Sudan (MD-Jammu & Kashmir, India), Dr. Cathy Ndiaye (PATH) & Dr. Rakesh Aggarwal

  • Update on one dose trial data findings
    Single-dose HPV Vaccination Efficacy among adolescent girls and young women in Kenya – KEN SHE trial

    Dr. Nelly Mugo
  • Costa Rica HPV Vaccine Trials
    Dr. Carolina Porras
  • DoRIS Trial
    Dr Deborah Watson Jones
  • Single dose HPV vaccine trials in India
    Dr Neerja Bhatla
  • Q&A

SESSION 10: PEER TO PEER LEARNING – WHAT IS NEEDED FOR HPV VACCINATION PROGRAM INTRODUCTION IN THE REGION?

SESSION 10A: PEER EXCHANGE LEARNING FROM HPV VACCINATION PROGRAM COMMUNICATION PLAN

Chairs: Ms. Roli Singh (AS, MD-NHM, India), Sonia Sarkar (UNICEF, India)& Dr. Sharon Hanley (Hokkaido University, Japan)

  • The importance of effective communication and the need for a crisis communication plan
    Country experience:

    Yvonne Morrisey (HSE NIO) – Ireland
    Dr Veena Dhawan – GoI
  • Communication tools for culturally sensitive context
    Tamara Abu Sham, UNICEF
  • Q&A

SESSION 10B: GROUP WORK: DISCUSSION ON NEEDS FOR VARIOUS PARAMETERS OF HPV VACCINATION PROGRAMS

Group work facilitators:
University of Antwerp: Dr. Alex Vorsters & Ms. Dur-e-Nayab Waheed (Online)
Jhpiego: Ms. Sarah Wanyoike & Ms. Elaine Charurat (Jhpiego, USA), Dr Apoorva Sharan & Dr. Prem Singh (Jhpiego, India)
Supporting chairs: Dr. Surinder Jaswal, Dr. Ranganai Matema (Health Specialist, UNICEF, India) & Dr. Ranbeer Singh (Asst. Dir. Cancer Program, CHAI, India), Quail Rogers-Bloch (JSI, USA)

  • What is needed for rolling out HPV vaccination programs?
    The participants will be given a work sheet to mention key points for several parameters of HPV vaccination programs in their respective state/region/country
    The following topics will be covered:
    – Macro- and micro-planning
    – Cold chain and vaccine management
    – Delivery approaches
    – Communication and social mobilization
    – Monitoring and evaluation
  • Rapid round of feedback from the Groups

DAY 3: INTRODUCTION

Welcome Note for Day 3

  • Dr. Parvaiz Koul (NITAG, India)

SESSION 11: CERVICAL CANCER SCREENING LANDSCAPE

SESSION 11A: CERVICAL CANCER SCREENING LANDSCAPE – GLOBAL OVERVIEW

Chairs: Dr. Marc Steben (Quebec’s National Public Health Institute, Canada) & Dr. Samorjit Ningombam (MD-Manipur, India)

  • Global overview on available assays for screening and treatment options for cervical cancer
    Dr. Maribel Almonte ( IARC) – Online
  • Lessons learned from cervical cancer screening program
    ROSE program
    Yogeeta Gunasagran(University Malaya Medical Centre Malaysia)
  • Experience from Turkey
    Dr. Murat Gultekin (Hacettepe University, Turkey)
  • Q&A

SESSION 11B: CERVICAL CANCER SCREENING LANDSCAPE IN SOUTH-ASIA

Chairs: Dr. Sharmila Pimple (India), Dr. Shabana Saleem (DGH, MoH-Pakistan) & Dr. Soe Lwin Nyein, Myanmar

  • Cervical cancer screening in India
    India – Dr Sudarsan Mandal, DDG (NCD), GoI

Country examples

  • Bangladesh
    Dr Jannatul Ferdous, Dr. Azizul Alim, GoB
  • Nepal
    Ms. Kabita Aryal, GoNP
  • Pakistan
    Prof. Dr. Sadia Ahsan Pal
  • Learning from cervical cancer screening program in Bhutan
    Ms. Jamyang Choden (Ministry of Health, Bhutan) – Online
  • Learning from Cervical Cancer Screening from Madhya Pradesh
    Mr. Ranveer B. Singh
  • Cervical cancer screening programs – LMICs experience
    Dr Somesh Kumar, JHPIEGO
  • Q&A

SESSION 11C (PANEL DISCUSSION): CERVICAL CANCER SCREENING AND TREATMENT CHALLENGES IN SOUTH ASIA

Chairs: Dr. Bhagyalaxmi Nayak (India) & Dr. Eduardo Franco (McGill University, Canada)

Overview of available cervical cancer screening and treatment options in the region

  • How can the countries in region transition from VIA to HPV testing?
  • How do we manage the availability of diagnostic and treatment tools?
  • Availability and training of health workforce to conduct screening?
  • How will the region deal with loss to follow-up for cervical cancer screening and false HPV positives due to HPV testing?
  • How cervical cancer screening can be logistically implemented in low resource settings? 

Panelists:
Global Exerts
Dr Silvia de Sanjose (Online)
Dr Murat Gultekin (Hacettepe University, Turkey)
Dr. Kim Mulholland
Dr. Susanne Kruger Kjaer (University of Copenhagen, Denmark) – Online
Dr. Marc Arbyn (Sciensano, Belgium) – Online
Dr. Nelly Mugo (KEMRI, Kenya)
Country experts
India – Dr Priya Abraham,
Bangladesh – Dr Choudhury Ali Kawsar
Maldives – Dr Aminath Nusra
Sri Lanka – Dr Padmaka de Silva
Pakistan – Prof. Dr. Sadia Ahsan Pal
Bhutan – Dr. Pempa (Ministry of Health, Bhutan)